FHCIX Holdings — Fidelity Advisor Health Care Fund
All 138 reported holdings of Fidelity Advisor Health Care Fund (FHCIX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| ELI LILLY and CO | 6.93% | $200.00M |
| Danaher Corp. | 6.79% | $195.95M |
| JOHNSON and JOHNSON | 5.67% | $163.65M |
| Thermo Fisher Scientific, Inc. | 3.62% | $104.41M |
| Unitedhealth Group, Inc. | 3.02% | $87.06M |
| Boston Scientific Corp. | 2.79% | $80.65M |
| Ascendis Pharma A/s | 2.70% | $77.99M |
| Alnylam Pharmaceuticals, Inc. | 2.44% | $70.56M |
| Gilead Sciences, Inc. | 2.27% | $65.42M |
| Abbvie, Inc. | 2.23% | $64.24M |
| Ucb SA | 2.05% | $59.15M |
| Argenx SE | 1.76% | $50.81M |
| Brightspring Health Services, Inc. | 1.66% | $47.97M |
| Cencora, Inc. | 1.53% | $44.20M |
| MERCK and CO INC | 1.51% | $43.67M |
| Insmed, Inc. | 1.50% | $43.35M |
| Edwards Lifesciences Corp. | 1.45% | $41.75M |
| Nuvalent, Inc. | 1.25% | $36.10M |
| Cvs Health Corp. | 1.23% | $35.65M |
| Fidelity Revere Street Trust | 1.21% | $34.93M |
| Moderna, Inc. | 1.21% | $34.91M |
| Cogent Biosciences, Inc. | 1.19% | $34.36M |
| Caris Life Sciences, Inc. | 1.18% | $34.20M |
| Xenon Pharmaceuticals, Inc. | 1.16% | $33.62M |
| Vaxcyte, Inc. | 1.07% | $30.91M |
| Spyre Therapeutics, Inc. | 1.06% | $30.52M |
| Royalty Pharma PLC | 1.02% | $29.55M |
| Privia Health Group, Inc. | 1.02% | $29.32M |
| Oruka Therapeutics, Inc. | 1.00% | $29.01M |
| Bio Techne Corp. | 0.96% | $27.66M |
| Medline, Inc. | 0.95% | $27.57M |
| Viatris, Inc. | 0.95% | $27.41M |
| Legend Biotech Corp. | 0.94% | $27.28M |
| Roche Holding AG | 0.92% | $26.49M |
| Crinetics Pharmaceuticals, Inc. | 0.90% | $25.98M |
| Natera, Inc. | 0.90% | $25.98M |
| Repligen Corp. | 0.88% | $25.44M |
| Alignment Healthcare, Inc. | 0.84% | $24.34M |
| Enliven Therapeutics, Inc. | 0.83% | $23.91M |
| West Pharmaceutical Svcs, Inc. | 0.82% | $23.81M |
| Axsome Therapeutics, Inc. | 0.81% | $23.27M |
| Disc Medicine, Inc. | 0.79% | $22.75M |
| Veracyte, Inc. | 0.76% | $22.06M |
| Kiniksa Pharmaceuticals International PLC | 0.75% | $21.51M |
| 10x Genomics, Inc. | 0.73% | $20.95M |
| Jazz Pharmaceuticals PLC | 0.70% | $20.30M |
| Intuitive Surgical, Inc. | 0.69% | $19.91M |
| Lifestance Health Group, Inc. | 0.66% | $18.93M |
| Cg Oncology, Inc. | 0.65% | $18.69M |
| Tenet Healthcare Corp. | 0.64% | $18.60M |
| Guardant Health, Inc. | 0.63% | $18.29M |
| Roivant Sciences Ltd. | 0.63% | $18.26M |
| Kymera Therapeutics, Inc. | 0.63% | $18.24M |
| Praxis Precision Medicines Inc. | 0.59% | $16.90M |
| Insulet Corp. | 0.58% | $16.87M |
| Mineralys Therapeutics, Inc. | 0.55% | $15.99M |
| Pharvaris Bv | 0.54% | $15.51M |
| Heartflow, Inc. | 0.52% | $14.88M |
| Revolution Medicines, Inc. | 0.50% | $14.41M |
| Bruker Corp. | 0.48% | $13.95M |
| Cytokinetics, Inc. | 0.48% | $13.95M |
| Faheal Tub Holdings LLC | 0.48% | $13.78M |
| Beone Medicines Ltd. | 0.47% | $13.58M |
| Veeva Sys, Inc. | 0.46% | $13.41M |
| Mckesson Corp. | 0.45% | $13.04M |
| Travere Therapeutics, Inc. | 0.42% | $12.21M |
| Structure Therapeutics, Inc. | 0.40% | $11.61M |
| Viridian Therapeutics, Inc. | 0.40% | $11.59M |
| Waystar Holding Corp. | 0.40% | $11.54M |
| Amylyx Pharmaceuticals, Inc. | 0.40% | $11.44M |
| Irhythm Technologies, Inc. | 0.38% | $10.98M |
| Olema Pharmaceuticals, Inc. | 0.37% | $10.81M |
| Stoke Therapeutics, Inc. | 0.37% | $10.80M |
| Cleerly, Inc. | 0.37% | $10.66M |
| Cytomx Therapeutics, Inc. | 0.37% | $10.55M |
| Newamsterdam Pharma Company NV | 0.35% | $10.00M |
| Mirum Pharmaceuticals, Inc. | 0.34% | $9.73M |
| Zenas Biopharma, Inc. | 0.33% | $9.66M |
| Mbx Biosciences, Inc. | 0.31% | $9.07M |
| Fidelity Revere Street Trust | 0.30% | $8.76M |
| Viking Therapeutics, Inc. | 0.30% | $8.73M |
| Kestra Medical Technologies, Inc. | 0.30% | $8.70M |
| Summit Therapeutics, Inc. | 0.30% | $8.58M |
| Elevance Health, Inc. | 0.27% | $7.90M |
| Dianthus Therapeutics, Inc. | 0.26% | $7.46M |
| Scholar Rock Holding Corp. | 0.26% | $7.46M |
| Immunocore Holdings PLC | 0.25% | $7.26M |
| Stryker Corp. | 0.25% | $7.18M |
| Damora Therapeutics, Inc. | 0.25% | $7.18M |
| Trevi Therapeutics, Inc. | 0.24% | $6.88M |
| Jade Biosciences, Inc. | 0.24% | $6.83M |
| Relay Therapeutics, Inc. | 0.22% | $6.48M |
| Medical Microinstruments, Inc. | 0.21% | $6.14M |
| Veradermics, Inc. | 0.21% | $5.94M |
| Endeavor Biomedicines, Inc. | 0.20% | $5.63M |
| Kardium Inc/us | 0.18% | $5.34M |
| Biogen, Inc. | 0.18% | $5.30M |
| Insightec Ltd. | 0.18% | $5.10M |
| Tyra Biosciences, Inc. | 0.17% | $4.87M |
| Apogee Therapeutics, Inc. | 0.16% | $4.59M |
| Annexon, Inc. | 0.15% | $4.40M |
| Almar Biosciences, Inc. | 0.15% | $4.21M |
| Element Biosciences, Inc. | 0.14% | $4.15M |
| Shoulder Innovations, Inc. | 0.14% | $3.97M |
| Aledade, Inc. | 0.13% | $3.81M |
| Alumis, Inc. | 0.13% | $3.72M |
| Upstream Bio, Inc. | 0.13% | $3.67M |
| Contineum Therapeutics, Inc. | 0.12% | $3.59M |
| Outset Medical, Inc. | 0.12% | $3.42M |
| Rallybio Corp. | 0.12% | $3.36M |
| Parabilis Medicines, Inc. | 0.11% | $3.07M |
| Kardium Inc/us | 0.10% | $2.84M |
| Candid Therapeutics | 0.09% | $2.74M |
| Ocular Therapeutix, Inc. | 0.09% | $2.60M |
| Zenas Biopharma, Inc. | 0.08% | $2.36M |
| Galvanize Therapeutics | 0.08% | $2.34M |
| Manus Bio, Inc. | 0.08% | $2.32M |
| Galvanize Therapeutics | 0.06% | $1.86M |
| Element Biosciences, Inc. | 0.06% | $1.82M |
| Element Biosciences, Inc. | 0.06% | $1.82M |
| Perceptive Capital Solutions Corp. | 0.06% | $1.69M |
| Asimov, Inc. | 0.06% | $1.68M |
| Wugen, Inc. | 0.05% | $1.49M |
| Faheal Thrive Holdings LLC | 0.05% | $1.48M |
| Dmed Biopharmaceutical Co. Ltd. | 0.05% | $1.42M |
| Aledade, Inc. | 0.05% | $1.36M |
| Kardium Inc/us | 0.04% | $1.17M |
| Saluda Medical, Inc. | 0.03% | $932.68K |
| Galvanize Therapeutics | 0.03% | $852.00K |
| Immunome, Inc. | 0.03% | $777.00K |
| Wugen, Inc. | 0.02% | $465.08K |
| Saluda Medical, Inc. | 0.01% | $419.44K |
| Cyclerion Therapeutics, Inc. | 0.01% | $337.04K |
| Elevatebio, LLC | 0.01% | $300.47K |
| Kardium Inc/us | 0.01% | $243.19K |
| Acumen Pharmaceuticals, Inc. | 0.01% | $201.78K |
| Medical Microinstruments, Inc. | 0.00% | $108.70K |
| Cyclerion Therapeutics, Inc. | 0.00% | $4.96K |
FHCIX overview: performance, fees, allocation and SEC filings